Related Experiment Video
Updated: Jun 6, 2025
09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
1.6K
IL-6 and Cardiovascular Risk: A Narrative Review
Nehal N Mehta1, Emil deGoma2, Michael D Shapiro3
1The George Washington University School of Medicine, Washington, DC, USA.
Current Atherosclerosis Reports
|November 26, 2024
Summary
Elevated interleukin-6 (IL-6) levels predict increased cardiovascular risk, including death and major adverse events. This inflammation marker is linked to atherosclerosis progression and heart failure, supporting IL-6 inhibition as a therapeutic target.
Area of Science:
- Cardiovascular Medicine
- Inflammation Biology
- Epidemiology
Background:
- Interleukin-6 (IL-6) is a pro-inflammatory cytokine implicated in various diseases.
- Understanding the role of IL-6 in cardiovascular disease (CVD) is crucial for risk stratification and treatment.
Purpose of the Study:
- To review recent prospective observational studies on the association between circulating IL-6 levels and cardiovascular outcomes.
- To synthesize evidence on IL-6's role in clinical and imaging cardiovascular endpoints.
Main Methods:
- Narrative review of prospective observational studies.
- Analysis of data linking IL-6 levels to cardiovascular clinical and imaging endpoints.
Main Results:
- Higher IL-6 levels correlate with increased risk of cardiovascular death, myocardial infarction, stroke, peripheral artery disease, and heart failure.
- IL-6 is associated with carotid intima-media thickness and plaque progression, severity, and vulnerability.
- Findings are consistent across diverse populations and robust after adjusting for traditional risk factors and high-sensitivity C-reactive protein.
Conclusions:
- IL-6 is a significant mediator of cardiovascular risk, supported by epidemiological, genetic, and mechanistic data.
- Ongoing trials are investigating IL-6 inhibition as a treatment strategy for atherosclerotic cardiovascular disease and heart failure.
Related Concept Videos
01:27Psychoneuroimmunology: Cardiovascular Disease
25
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
25
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
59
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
59
01:23Assessment of the Cardiovascular System I: Subjective Data
278
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
278
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
3
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3